Dana Farber — Boston, Massachusetts

Dana Farber is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Dana Farber has participated in 19 clinical trials with 4 currently active.

Therapeutic areas: Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma.

Sponsors: Linnaeus Therapeutics, Inc., University of Michigan Rogel Cancer Center, Therapeutic Advances in Childhood Leukemia Consortium.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber?

Dana Farber has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber conducted?

Dana Farber has 19 clinical trials on record, with 4 currently active. Their work covers Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma.

Is Dana Farber accredited by Crixeo Health?

Yes — Dana Farber holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Dana Farber?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.